236 related articles for article (PubMed ID: 27314204)
1. Systemic delivery of siRNA by hyaluronan-functionalized calcium phosphate nanoparticles for tumor-targeted therapy.
Qiu C; Wei W; Sun J; Zhang HT; Ding JS; Wang JC; Zhang Q
Nanoscale; 2016 Jul; 8(26):13033-44. PubMed ID: 27314204
[TBL] [Abstract][Full Text] [Related]
2. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
[TBL] [Abstract][Full Text] [Related]
3. Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
Yu MZ; Pang WH; Yang T; Wang JC; Wei L; Qiu C; Wu YF; Liu WZ; Wei W; Guo XY; Zhang Q
Eur J Pharm Sci; 2016 Sep; 92():39-48. PubMed ID: 27355138
[TBL] [Abstract][Full Text] [Related]
4. Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate.
Lee MS; Lee JE; Byun E; Kim NW; Lee K; Lee H; Sim SJ; Lee DS; Jeong JH
J Control Release; 2014 Oct; 192():122-30. PubMed ID: 24995950
[TBL] [Abstract][Full Text] [Related]
5. Bioreducible Cross-Linked Hyaluronic Acid/Calcium Phosphate Hybrid Nanoparticles for Specific Delivery of siRNA in Melanoma Tumor Therapy.
Zhou Z; Li H; Wang K; Guo Q; Li C; Jiang H; Hu Y; Oupicky D; Sun M
ACS Appl Mater Interfaces; 2017 May; 9(17):14576-14589. PubMed ID: 28393529
[TBL] [Abstract][Full Text] [Related]
6. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
7. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.
Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC
Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198
[TBL] [Abstract][Full Text] [Related]
8. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of hyaluronic-acid-modified chitosan nanoparticles loaded with siRNA for targeted therapy for non-small cell lung cancer.
Zhang W; Xu W; Lan Y; He X; Liu K; Liang Y
Int J Nanomedicine; 2019; 14():5287-5301. PubMed ID: 31406460
[No Abstract] [Full Text] [Related]
10. Targeted co-delivery of Beclin 1 siRNA and FTY720 to hepatocellular carcinoma by calcium phosphate nanoparticles for enhanced anticancer efficacy.
Wu JY; Wang ZX; Zhang G; Lu X; Qiang GH; Hu W; Ji AL; Wu JH; Jiang CP
Int J Nanomedicine; 2018; 13():1265-1280. PubMed ID: 29551896
[TBL] [Abstract][Full Text] [Related]
11. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties.
Yin T; Liu J; Zhao Z; Dong L; Cai H; Yin L; Zhou J; Huo M
J Control Release; 2016 Dec; 243():54-68. PubMed ID: 27702595
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles.
Pittella F; Miyata K; Maeda Y; Suma T; Watanabe S; Chen Q; Christie RJ; Osada K; Nishiyama N; Kataoka K
J Control Release; 2012 Aug; 161(3):868-74. PubMed ID: 22580114
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional nanoparticles co-delivering EZH2 siRNA and etoposide for synergistic therapy of orthotopic non-small-cell lung tumor.
Yuan ZQ; Chen WL; You BG; Liu Y; Yang SD; Li JZ; Zhu WJ; Zhou XF; Liu C; Zhang XN
J Control Release; 2017 Dec; 268():198-211. PubMed ID: 29061511
[TBL] [Abstract][Full Text] [Related]
14. Stabilized calcium phosphate hybrid nanocomposite using a benzoxaborole-containing polymer for pH-responsive siRNA delivery.
Zhou Q; Wang Y; Xiang J; Piao Y; Zhou Z; Tang J; Liu X; Shen Y
Biomater Sci; 2018 Nov; 6(12):3178-3188. PubMed ID: 30327807
[TBL] [Abstract][Full Text] [Related]
15. Versatile RNA interference nanoplatform for systemic delivery of RNAs.
Choi KY; Silvestre OF; Huang X; Min KH; Howard GP; Hida N; Jin AJ; Carvajal N; Lee SW; Hong JI; Chen X
ACS Nano; 2014 May; 8(5):4559-70. PubMed ID: 24779637
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.
Ganesh S; Iyer AK; Morrissey DV; Amiji MM
Biomaterials; 2013 Apr; 34(13):3489-502. PubMed ID: 23410679
[TBL] [Abstract][Full Text] [Related]
17. F127/Calcium phosphate hybrid nanoparticles: a promising vector for improving siRNA delivery and gene silencing.
Qin L; Sun Y; Liu P; Wang Q; Han B; Duan Y
J Biomater Sci Polym Ed; 2013; 24(15):1757-66. PubMed ID: 23746331
[TBL] [Abstract][Full Text] [Related]
18. CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy.
Wang Z; Wang L; Prabhakar N; Xing Y; Rosenholm JM; Zhang J; Cai K
Acta Biomater; 2019 Mar; 86():416-428. PubMed ID: 30611792
[TBL] [Abstract][Full Text] [Related]
19. Microfluidic-Based Holonomic Constraints of siRNA in the Kernel of Lipid/Polymer Hybrid Nanoassemblies for Improving Stable and Safe In Vivo Delivery.
Wei W; Sun J; Guo XY; Chen X; Wang R; Qiu C; Zhang HT; Pang WH; Wang JC; Zhang Q
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14839-14854. PubMed ID: 32182035
[TBL] [Abstract][Full Text] [Related]
20. Systemic siRNA delivery to tumors by cell-penetrating α-helical polypeptide-based metastable nanoparticles.
Liu Y; Song Z; Zheng N; Nagasaka K; Yin L; Cheng J
Nanoscale; 2018 Aug; 10(32):15339-15349. PubMed ID: 30070662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
